<?xml version="1.0" encoding="UTF-8"?>
<p>Treatment options for RSV are limited to supportive care or ribavirin with only marginal effectiveness. Leflunomide showed a potent, dose-dependent anti-RSV activity in cell cultures.
 <sup>
  <xref rid="bibr92-1759720X20947296" ref-type="bibr">92</xref>
 </sup> Also, pulmonary viral loads were prominently reduced in cotton rats, even if there was a 3-day delay of leflunomide administration after viral inoculation.
 <sup>
  <xref rid="bibr109-1759720X20947296" ref-type="bibr">109</xref>
 </sup>
</p>
